Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
作者： S Branford , Z Rudzki , A Harper , A Grigg , K Taylor
关键词:
摘要: Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia phase
nature.com
core.ac.uk
sahmriresearch.org参考文章(35)
TP Hughes, GJ Morgan, P Martiat, JM Goldman, Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood. ,vol. 77, pp. 874- 878 ,(1991) , 10.1182/BLOOD.V77.4.874.874
A.G. Elefanty, I.K. Hariharan, S. Cory, bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. The EMBO Journal. ,vol. 9, pp. 1069- 1078 ,(1990) , 10.1002/J.1460-2075.1990.TB08212.X
A Gaiger, T Henn, E Horth, K Geissler, G Mitterbauer, T Maier-Dobersberger, H Greinix, C Mannhalter, OA Haas, K Lechner, Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression Blood. ,vol. 86, pp. 2371- 2378 ,(1995) , 10.1182/BLOOD.V86.6.2371.BLOODJOURNAL8662371
JP Radich, G Gehly, T Gooley, E Bryant, RA Clift, S Collins, S Edmands, J Kirk, A Lee, P Kessler, Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients Blood. ,vol. 85, pp. 2632- 2638 ,(1995) , 10.1182/BLOOD.V85.9.2632.BLOODJOURNAL8592632
Susan Branford, Zbigniew Rudzki, Sonya Walsh, Andrew Grigg, Chris Arthur, Kerry Taylor, Richard Herrmann, Kevin P. Lynch, Timothy P. Hughes, High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance. Blood. ,vol. 99, pp. 3472- 3475 ,(2002) , 10.1182/BLOOD.V99.9.3472
Feng Lin, Mark Drummond, Stephen O'Brien, Francisco Cervantes, John Goldman, Jaspal Kaeda, Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib Blood. ,vol. 102, pp. 1143- 1143 ,(2003) , 10.1182/BLOOD-2002-12-3916
Nora Heisterkamp, Guido Jenster, Joanne ten Hoeve, Daniel Zovich, Paul K. Pattengale, John Groffen, Acute leukaemia in bcr/abl transgenic mice Nature. ,vol. 344, pp. 251- 253 ,(1990) , 10.1038/344251A0
Amie S Corbin, Elisabeth Buchdunger, Furet Pascal, Brian J Druker, None, Analysis of the structural basis of specificity of inhibition of the Abl kinase by STI571. Journal of Biological Chemistry. ,vol. 277, pp. 32214- 32219 ,(2002) , 10.1074/JBC.M111525200
Lihui Wang, Kevin Pearson, Julia E. Ferguson, Richard E. Clark, The early molecular response to imatinib predicts cytogenetic and clinical outcome in chronic myeloid leukaemia British Journal of Haematology. ,vol. 120, pp. 990- 999 ,(2003) , 10.1046/J.1365-2141.2003.04200.X
G.J. Morgan, J.W.G. Janssen, Ai-Pu Guo, L.M. Wiedemann, T. Hughes, J. Gow, J.M. Goldman, C.R. Bartram, Polymerase chain reaction for detection of residual leukaemia. The Lancet. ,vol. 333, pp. 928- 929 ,(1989) , 10.1016/S0140-6736(89)92508-7